HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 25.80
Day range
zł 25.05 - zł 25.80
Year range
zł 17.62 - zł 40.00
Market cap
586.10M PLN
Avg Volume
60.79K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 19.50M | -22.12% |
Operating expense | 41.28M | -8.45% |
Net income | -24.71M | 6.99% |
Net profit margin | -126.73 | -19.41% |
Earnings per share | — | — |
EBITDA | -22.90M | -0.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 136.56M | -44.84% |
Total assets | 255.34M | -36.67% |
Total liabilities | 184.12M | -18.33% |
Total equity | 71.22M | — |
Shares outstanding | 23.12M | — |
Price to book | 8.38 | — |
Return on assets | -14.54% | — |
Return on capital | -18.51% | — |
Cash Flow
Net change in cash
| (PLN) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -24.71M | 6.99% |
Cash from operations | -108.33M | 9.87% |
Cash from investing | 23.74M | -84.87% |
Cash from financing | 22.07M | -81.62% |
Net change in cash | -62.85M | -140.09% |
Free cash flow | 36.00M | 234.31% |
About
Founded
2007
Website
Employees
328
